Effectiveness of Audio Cues to Achieve Positional Therapy in Patients With Positional Obstructive Sleep Apnea
Part of paid clinical trials in Burlingame, California.
- Sponsor
- SleepDev, Inc
- Study ID
- NCT07714330
- Status
- Recruiting
Conditions
- Obstructive Sleep Apnea (OSA)
- Positional Obstructive Sleep Apnea
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- Investigational Positional Therapy Device — DEVICEThe investigational intervention is a non-invasive, investigational in-ear positional therapy device worn in the ear during sleep. The device continuously monitors head position and delivers gentle audio cues when the participant remains in the supine (back-sleeping) position to encourage a return to a non-supine sleeping position. The device is evaluated as part of a structured protocol including baseline assessment, acclimation, and treatment nights.
Study Details
Patients with obstructive sleep apnea (OSA) often experience more frequent and severe breathing disturbances when sleeping in the supine (back-sleeping) position compared with non-supine positions. Positional therapy aims to reduce time spent sleeping in the supine position, but existing treatment options may be limited by comfort and effectiveness. This study evaluates the effectiveness and usability of WhisperPT, an investigational in-ear positional therapy device that delivers gentle audio cues during sleep to encourage participants to move from the supine to a non-supine sleeping position. The study will assess the device's ability to reduce the apnea-hypopnea index (AHI), decrease time spent sleeping supine, and evaluate participant comfort and ease of use.
Key Dates
- First listed
- Jul 20, 2026
- Start date
- Jun 25, 2026
- Status verified
- Jul 2026
- Primary completion
- Sep 30, 2026
- Completion
- Dec 30, 2026
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Investigational Positional Therapy Device
Primary Outcome Measure
Participants Achieving ≥50% Reduction in AHI [ Time Frame: Intervention assessment (Night 5), within approximately 7 days ]
Central Contacts
- Michael Swertfager408-499-6884
- Joshua Roland, M.D.
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Peninsula Sleep Center | Burlingame | California | 94010 | Mehran Farid, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Burlingame, CA
Related Studies
- Diagnosing Obstructive Sleep Apnea Using Electromyography of the Muscles of the MouthRecruiting · University of California, San Diego · San Diego, California
- Endotype DIrected Treatment for OSA in Down SyndromePHASE4 · Recruiting · University of Arizona · Tucson, Arizona
- DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.PHASE2 · Not Yet Recruiting · Incannex Healthcare Ltd · Chula Vista, California
- A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in AdultsPHASE4 · Not Yet Recruiting · Sairam Parthasarathy · Tucson, Arizona